Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
造血干细胞移植后的副流感病毒感染：危险因素、对抗病毒治疗的反应以及对移植预后的影响。
The expanded indication makes lenalidomide the first and only treatment to receive FDA approval for maintenance use following autologous hematopoietic stem cell transplant.
来那度胺适应症扩展后，成为FDA批准的第一个也是唯一的用于自体造血干细胞移植后维持治疗的药物。
Invasive fungal infection (IFI) is an important cause of morbidity and mortality in patients with hematologic malignancy, prolonged neutropenia, or after hematopoietic stem cell transplant.
侵袭性真菌感染(ifi)是恶性血液病、长时间中性粒细胞减少或造血干细胞移植后患者重要的发病和死亡原因之一。
The majority of people had received chemotherapy for a haematological malignancy or had undergone a hematopoietic stem cell transplant.
大多数人接受了恶性血液肿瘤化疗或造血干细胞移植。
DNA samples of related hematopoietic stem cell transplant donor-recipients were extracted from peripheral blood cells. HLA-A loci were typed both by RSCA and PCR-SSP.
然后分别提取84例拟进行造血干细胞移植病人及家系成员的外周血d NA，采用RSCA和序列特异性引物体外基因扩增(PCRssp)法平行对照对HLA A基因位点进行分型。
DNA samples of related hematopoietic stem cell transplant donor-recipients were extracted from peripheral blood cells. HLA-A loci were typed both by RSCA and PCR-SSP.
然后分别提取84例拟进行造血干细胞移植病人及家系成员的外周血d NA，采用RSCA和序列特异性引物体外基因扩增(PCRssp)法平行对照对HLA A基因位点进行分型。
应用推荐